China’s leading class looks to first-in-class

The next wave of Chinese leading companies is bringing innovative products to the clinic, with at least 37 programs against 29 targets with the potential to be first in class. 

For each target, no products are currently approved against that target in that disease area, but several targets have multiple companies racing to be first to market. ...